Motif Bio plc | CIK:0001674657 | 3

  • Filed: 4/10/2018
  • Entity registrant name: Motif Bio plc (CIK: 0001674657)
  • Generator: Merrill
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1674657/000110465918023117/0001104659-18-023117-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1674657/000110465918023117/mtfb-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001674657
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory

     

    f.Impairment of non-financial assets

     

    Assets that have an indefinite useful life are not subject to amortization and are tested annually in the second half of each fiscal year for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired.  Other assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount.  The recoverable amount is the higher of an asset’s fair value less costs of disposal and value in use.  For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash inflows which are largely independent of the cash inflows from other assets or groups of assets (cash-generating units).  Non-financial assets other than goodwill that suffered an impairment are reviewed for possible reversal of the impairment at the end of each reporting period.